Share this post on:

Name:

Mavrilimumab Biosimilar, Anti-CD116/CSF2RA

Host species:

Homo sapiens

Species reactivity:

Human

Form:

solution

Storage buffer:

0.01M PBS, pH 7.4.

Concentration:

1 mg/ml

Purity:

>95%.category:Monoclonal

Isotype:

IgG4-lambda2

Applications:

Biosimilar

For research use only. We do not sell to patients.

Target:

CD116, CSF2R, GMR-alpha, CSF2RA, Granulocyte-macrophage colony-stimulating factor receptor subunit alpha, CSF2RY, GMCSFR-alpha, GM-CSF-R-alpha, CDw116

Purification:

Protein A/G purified from cell culture supernatant.

Endotoxin level:

Please contact with the lab for this information.

Expression system:

MammalianP15509https://www.ncbi.nlm.nih.gov/protein/P15509

Stability and Storage:

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4C short term

1-2 weeks:

.Store at -20 C 12 months. Store at -80C long term.

Alternative Names:

CAM-3001, CAS: 1085337-57-0Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AHR Antibody
Phospho-NF-κB p65 (Ser529) Antibody
C5b-9 Antibody: C5b-9 Antibody is an unconjugated, rabbit-derived, anti-C5b-9 polyclonal antibody. C5b-9 Antibody can be used for: WB, IHC-P, IHC-F, IF expriments in human, rat, and predicted: mouse background without labeling.

Share this post on:

Author: signsin1dayinc